Home/ Stocks/ XENE

Xenon Pharmaceuticals Inc

XENE XNAS

$56.44 +0.44 (+0.79%) ▲ 15-min delayed

Open

$56.13

High

$57.47

Low

$55.73

Volume

920.5K

Market Cap

$5.46B

About Xenon Pharmaceuticals Inc

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 370 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$0	$-102,302,000	$-1.17
FY 2025	$7.50M	$-345,910,000	$-4.36
Q3 2025	$0	$-90,896,000	$-1.15
Q2 2025	$0	$-84,706,000	$-1.07

Related Market News

No specific coverage for XENE yet. Check out our latest market news or earnings calendar.

Get XENE Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Xenon Pharmaceuticals Inc.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.